Medpace(MEDP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MEDP Medpace

Post-Mkt 04-22 16:57:21 EDT

508.46

-6.44

-1.25%

盘后408.42

-100.04-19.68%

16:57 EDT

High527.75	Low503.77	Vol422.96K
Open519.39	D1 Closing514.90	Amplitude4.66%
Mkt Cap14.52B	Tradable Cap11.30B	Total Shares28.56M
T/O214.19M	T/O Rate1.90%	Tradable Shares22.22M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MEDP","market":"US","secType":"STK","nameCN":"Medpace","latestPrice":508.46,"timestamp":1776888000000,"preClose":514.9,"halted":0,"volume":422960,"hourTrading":{"tag":"盘后","latestPrice":408.42,"preClose":508.46,"latestTime":"16:57 EDT","volume":32021,"amount":14016694.50324,"timestamp":1776891428377,"change":-100.04,"changeRate":-0.196751,"amplitude":0.198167},"delay":0,"changeRate":-0.012507282967566515,"floatShares":22220178,"shares":28558039,"eps":15.28,"marketStatus":"Post-Mkt","change":-6.44,"latestTime":"04-22 16:57:21 EDT","open":519.39,"high":527.75,"low":503.7701,"amount":214191554.264,"amplitude":0.046572,"askPrice":408.42,"askSize":47,"bidPrice":407.5,"bidSize":5,"shortable":3,"etf":0,"ttmEps":15.28,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1776902400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1470888000000,"exchange":"NASDAQ","adjPreClose":514.9,"preHourTrading":{"tag":"盘前","latestPrice":518.99,"preClose":514.9,"latestTime":"09:29 EDT","volume":81,"amount":41815.088460000006,"timestamp":1776864599999,"change":4.09,"changeRate":0.007943,"amplitude":0.084463},"postHourTrading":{"tag":"盘后","latestPrice":408.42,"preClose":508.46,"latestTime":"16:57 EDT","volume":32021,"amount":14016694.50324,"timestamp":1776891428377,"change":-100.04,"changeRate":-0.196751,"amplitude":0.198167},"volumeRatio":0.945188,"impliedVol":0.7179,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/MEDP/wiki","defaultTab":"wiki","newsList":[{"id":"2629020100","title":"Medpace Hldgs Q1 EPS $4.28 Beats $3.88 Estimate, Sales $706.604M Beat $697.656M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2629020100","media":"Benzinga","labels":["express"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/2629020100?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:19","pubTimestamp":1776889172,"startTime":"0","endTime":"0","summary":"Medpace Hldgs (NASDAQ:MEDP) reported quarterly earnings of $4.28 per share which beat the analyst consensus estimate of $3.88 by 10.31 percent. This is a 16.62 percent increase over earnings of $3.67 per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/04/51984620/medpace-hldgs-q1-eps-4-28-beats-3-88-estimate-sales-706-604m-beat-697-656m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Medpace Hldgs Q1 EPS $4.28 Beats $3.88 Estimate, Sales $706.604M Beat $697.656M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629207845","title":"Medpace Holdings Inc - Forecasts 2026 Revenue $2.755 Bln-$2.855 Bln, up 8.9%-12.8% - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2629207845","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629207845?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:38","pubTimestamp":1776890327,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nFWN4151BV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDP","BK4121","BK4588","LU2065170008.USD","BK4585","LU2065171311.SGD","LU2065171402.SGD","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629078083","title":"Medpace Holdings Inc  FY2026 REV View $2.81 Bln -- Lseg Ibes Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2629078083","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629078083?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:38","pubTimestamp":1776890327,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nFWN4151BV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDP","LU2065170008.USD","BK4588","BK4121","LU2065171402.SGD","LU2065169927.USD","BK4585","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629078015","title":"Medpace Holdings Inc - Q1 2026 Gaap Net Income $123.9 Mln, $4.28 per Diluted Share - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2629078015","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629078015?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:38","pubTimestamp":1776890327,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nFWN4151BV:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","LU2065169927.USD","LU2065171311.SGD","LU2065171402.SGD","LU2065170008.USD","BK4588","BK4585","MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178135472","title":"Stock Track | Medpace Plunges 16.41% in After-Hours Trading Following Investor Lawsuit Over Alleged Misleading Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1178135472","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178135472?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:32","pubTimestamp":1776889960,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc. (MEDP) experienced a significant after-hours plunge of 16.41% on Wednesday, despite reporting first-quarter revenue that exceeded analyst expectations.The sharp decline appears...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629786720","title":"GUIDANCE: (MEDP) Medpace Expects 2026 Revenue Range $2.755B-$2.855B, vs. FactSet Est of $2.81B","url":"https://stock-news.laohu8.com/highlight/detail?id=2629786720","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629786720?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:29","pubTimestamp":1776889793,"startTime":"0","endTime":"0","summary":"GUIDANCE: (MEDP) Medpace Expects 2026 Revenue Range $2.755B-$2.855B, vs. FactSet Est of $2.81B","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629907867","title":"Earnings Flash (MEDP) Medpace Posts Q1 EPS $4.28, vs. FactSet Est of $3.92","url":"https://stock-news.laohu8.com/highlight/detail?id=2629907867","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629907867?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:29","pubTimestamp":1776889776,"startTime":"0","endTime":"0","summary":"Earnings Flash (MEDP) Medpace Posts Q1 EPS $4.28, vs. FactSet Est of $3.92","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629107836","title":"Medpace Q1 GAAP net income rises 8.1% to $123.9 million; revenue jumps 26.5% to $706.6 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2629107836","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629107836?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:26","pubTimestamp":1776889597,"startTime":"0","endTime":"0","summary":"Medpace posted first-quarter 2026 GAAP net income of USD 123.9 million, up 8.1%.Revenue climbed 26.5% to USD 706.6 million, representing a 23.3% backlog conversion rate.EBITDA increased 25.9% to USD 149.4 million, with EBITDA margin of 21.1%.Net new business awards rose 23.7% to USD 618.4 million, producing a net book-to-bill ratio of 0.88x.Full-year 2026 guidance calls for revenue of USD 2.755 billion to USD 2.855 billion, with GAAP net income of USD 487 million to USD 511 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDLRJCyj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","BK4121","BK4588","MEDP","LU2065169927.USD","LU2065171311.SGD","BK4585","LU2065170008.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629702093","title":"BRIEF-Medpace Q1 Revenue USD 706.604 Million Vs. IBES Estimate USD 697.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2629702093","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629702093?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:15","pubTimestamp":1776888946,"startTime":"0","endTime":"0","summary":"BRIEF-Medpace Q1 Revenue USD 706.604 Million Vs. IBES Estimate USD 697.7 Million\n\n\nApr 22 (Reuters) - Medpace Q1 net income USD 123.87 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nPLXD9509E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","MEDP","BK4121","LU2065171311.SGD","LU2065169927.USD","BK4585","LU2065171402.SGD","LU2065170008.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629780190","title":"Medpace Holdings Inc: on April 21, 2026, Jesse Geiger Notified Company of His Intent to Resign as President","url":"https://stock-news.laohu8.com/highlight/detail?id=2629780190","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629780190?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:15","pubTimestamp":1776888901,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nPLXD9509E:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4585","LU2065171402.SGD","LU2065170008.USD","BK4121","MEDP","LU2065169927.USD","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629738650","title":"Medpace Outlook FY Revenue USD 2,755-2,855 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2629738650","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629738650?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:15","pubTimestamp":1776888901,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nPLXD9509E:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","LU2065170008.USD","MEDP","BK4121","LU2065171311.SGD","LU2065171402.SGD","BK4585","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629359073","title":"Medpace Outlook FY Ebitda USD 605-605 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2629359073","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629359073?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:15","pubTimestamp":1776888901,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nPLXD9509E:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","LU2065169927.USD","LU2065171311.SGD","LU2065171402.SGD","LU2065170008.USD","BK4588","BK4585","MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629073840","title":"Medpace Outlook FY EPS USD 16.68-17.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2629073840","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629073840?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:15","pubTimestamp":1776888901,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nPLXD9509E:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065171402.SGD","BK4121","LU2065169927.USD","BK4585","LU2065171311.SGD","LU2065170008.USD","BK4588","MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629024046","title":"Medpace Holdings Faces Investor Lawsuit Over Alleged Misleading Book-to-Bill Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2629024046","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629024046?lang=en_us&edition=fundamental","pubTime":"2026-04-23 02:58","pubTimestamp":1776884339,"startTime":"0","endTime":"0","summary":"Medpace (MEDP) told investors cancellations were “well behaved” and that a 1.15 book-to-bill target remained achievable for the second half of 2025...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/medpace-holdings-faces-investor-lawsuit-over-alleged-misleading-book-to-bill-guidance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/medpace-holdings-faces-investor-lawsuit-over-alleged-misleading-book-to-bill-guidance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4121","BK4588","LU2065171402.SGD","MEDP","LU2065170008.USD","LU2065171311.SGD","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627257634","title":"RBC Capital Remains a Buy on Medpace Holdings (MEDP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627257634","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627257634?lang=en_us&edition=fundamental","pubTime":"2026-04-16 09:58","pubTimestamp":1776304738,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Ryan Halsted maintained a Buy rating on Medpace Holdings yesterday and set a price target of $522.00. According to TipRanks, Ha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-medpace-holdings-medp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-medpace-holdings-medp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0708994859.HKD","LU0029864427.USD","BK4207","LU1267930573.SGD","LU2065170008.USD","LU0128525929.USD","LU2065171311.SGD","LU2065171402.SGD","LU0310800379.SGD","LU2065169927.USD","MEDP","BK4121","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119655436","title":"Earning Preview: Medpace this quarter’s revenue is expected to increase by 32.55%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1119655436","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119655436?lang=en_us&edition=fundamental","pubTime":"2026-04-15 12:35","pubTimestamp":1776227708,"startTime":"0","endTime":"0","summary":"Abstract Medpace will report first‑quarter 2026 results on April 22, 2026, Post Market, with consensus pointing to strong year‑over‑year gains in revenue and adjusted EPS as investors watch backlog...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: Medpace this quarter’s revenue is expected to increase by 32.55%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626924581","title":"Medpace Holdings Investors Face Lawsuit Over Alleged Misleading Guidance on Key Business Metric","url":"https://stock-news.laohu8.com/highlight/detail?id=2626924581","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626924581?lang=en_us&edition=fundamental","pubTime":"2026-04-09 03:26","pubTimestamp":1775676398,"startTime":"0","endTime":"0","summary":"Medpace (MEDP) told investors cancellations were “well behaved” and a 1.15 book-to-bill was still in reach. Growth looked steady. Backlog looked st...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/medpace-holdings-investors-face-lawsuit-over-alleged-misleading-guidance-on-key-business-metric?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/medpace-holdings-investors-face-lawsuit-over-alleged-misleading-guidance-on-key-business-metric?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065171402.SGD","MEDP","BK4211","BK4121","BK4585","LU2065171311.SGD","ISBC","BK4588","LU2065170008.USD","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626792576","title":"Taking A Fresh Look At Medpace Holdings (MEDP) Valuation After Recent Share Price Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=2626792576","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626792576?lang=en_us&edition=fundamental","pubTime":"2026-04-09 00:22","pubTimestamp":1775665371,"startTime":"0","endTime":"0","summary":"Recent Performance Snapshot\nMedpace Holdings (MEDP) has attracted attention after recent share price moves, with the stock up about 2.5% over the past day, 5.9% over the past week, and 8.1% over the past month.\nSee our latest analysis for Medpace Holdings.\nThat short term 1 day share price return of 2.5% and 1 month share price return of 8.1% sit against a 90 day share price decline of 17.1% and a 1 year total shareholder return of 83.4%. This suggests momentum has picked up again after a...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-medp/medpace-holdings/news/taking-a-fresh-look-at-medpace-holdings-medp-valuation-after","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-medp/medpace-holdings/news/taking-a-fresh-look-at-medpace-holdings-medp-valuation-after","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2065171311.SGD","LU2065169927.USD","MEDP","BK4121","DCF","LU2065170008.USD","BK4588","BK4585","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625981950","title":"Medpace Holdings (MEDP) Is Up 7.8% After GLP-1 Trials Drive 32% Revenue Jump – What’s Changed","url":"https://stock-news.laohu8.com/highlight/detail?id=2625981950","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625981950?lang=en_us&edition=fundamental","pubTime":"2026-04-07 10:18","pubTimestamp":1775528333,"startTime":"0","endTime":"0","summary":"In the fourth quarter of 2025, Medpace Holdings reported a 32% year-over-year revenue increase, while Mairs & Power Small Cap Fund cited the company as a key contributor in its investor letter due to stronger clinical trial trends linked to GLP-1 programs.\nThis combination of healthier trial cancellation patterns and momentum in GLP-1 research highlights how Medpace is benefiting from current demand in metabolic-related clinical development.\nWe’ll now explore how this improved GLP-1-driven...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-medp/medpace-holdings/news/medpace-holdings-medp-is-up-78-after-glp-1-trials-drive-32-r","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-medp/medpace-holdings/news/medpace-holdings-medp-is-up-78-after-glp-1-trials-drive-32-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MEDP","GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624428785","title":"Medpace announces annual shareholder meeting invitation and proxy statement filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2624428785","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624428785?lang=en_us&edition=fundamental","pubTime":"2026-04-02 05:31","pubTimestamp":1775079090,"startTime":"0","endTime":"0","summary":"Shareholders will vote on election of five directors, including Brian T. Carley, Femida H. Gwadry-Sridhar, Robert O. Kraft, August J. Troendle, Dani S. Zander.Advisory votes set on executive pay, including frequency of future say-on-pay votes.Items include charter amendments to remove supermajority voting requirements, lift limits on shareholders calling special meetings, vote on shareholder proposal on special meeting rights.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medpace Holdings Inc. published the original content used to generate this news brief on April 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL5F7Tc2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2065170008.USD","LU2065171311.SGD","LU2065171402.SGD","LU2065169927.USD","MEDP","BK4121","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.medpace.com","stockEarnings":[{"period":"1week","weight":-0.0098},{"period":"1month","weight":0.1379},{"period":"3month","weight":-0.1703},{"period":"6month","weight":-0.137},{"period":"1year","weight":0.7817},{"period":"ytd","weight":-0.0832}],"compareEarnings":[{"period":"1week","weight":0.0139},{"period":"1month","weight":0.0856},{"period":"3month","weight":0.0273},{"period":"6month","weight":0.0481},{"period":"1year","weight":0.3701},{"period":"ytd","weight":0.0325}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.006402},{"month":2,"riseRate":0.3,"avgChangeRate":-0.035449},{"month":3,"riseRate":0.7,"avgChangeRate":0.006916},{"month":4,"riseRate":0.7,"avgChangeRate":0.012316},{"month":5,"riseRate":0.444444,"avgChangeRate":0.020283},{"month":6,"riseRate":1,"avgChangeRate":0.07437},{"month":7,"riseRate":0.666667,"avgChangeRate":0.148095},{"month":8,"riseRate":0.666667,"avgChangeRate":0.032832},{"month":9,"riseRate":0.6,"avgChangeRate":-0.004448},{"month":10,"riseRate":0.5,"avgChangeRate":0.057543},{"month":11,"riseRate":0.7,"avgChangeRate":0.057867},{"month":12,"riseRate":0.7,"avgChangeRate":0.025222}],"exchange":"NASDAQ","name":"Medpace","nameEN":"Medpace"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Medpace(MEDP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Medpace(MEDP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Medpace,MEDP,Medpace股票,Medpace股票老虎,Medpace股票老虎国际,Medpace行情,Medpace股票行情,Medpace股价,Medpace股市,Medpace股票价格,Medpace股票交易,Medpace股票购买,Medpace股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Medpace(MEDP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Medpace(MEDP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}